genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Eli Lilly
Eli Lilly Plans $400M Manufacturing Expansion
Bioprocessing
FUJIFILM Expands its Gene Therapy Services
News
Gut Microbiota Imbalance Linked with Epigenetic Changes, Promotes Colorectal Cancer
Genetics
Key Genetic Regulators of Parkinson’s Disease Identified
Vertex Pharmaceuticals
CRISPR Therapeutics, Vertex Report First Data from Trials of Gene-Editing Treatment…
Insights
Bioprocessing
Gene Therapy Companies’ Demands Reshape CDMOs
Bioprocessing
Building Bioprocessing from Data
Cell Therapy
“Squeezing” Cells Could Transform Cell Therapy Manufacturing
Insights
2020 Vision: Predictions of What May Shape Precision Medicine
Insights
How to Use CRISPR for Site-Specific Epigenetic Editing in the Nervous…
A-Lists
Drug Discovery
Top 10 Pharma Companies of 2019
A-Lists
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
GEN Edge
Top 10 U.S. Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Eli Lilly
Eli Lilly Plans $400M Manufacturing Expansion
Bioprocessing
FUJIFILM Expands its Gene Therapy Services
Bioprocessing
Gene Therapy Companies’ Demands Reshape CDMOs
Bioprocessing
Building Bioprocessing from Data
Magazine
November 2019 Vol. 39 No. 11
Synthetic Biology Seizes New Ground in Healthcare
November 2019 Vol. 39 No. 11
Agrigenomics Yields a Next-Gen Cornucopia
November 2019 Vol. 39 No. 11
Protein-Protein Interactions Get a New Groove On
Commentary
Machine Learning Enhances Cytometry Analysis
November 2019 Vol. 39 No. 11
Biomarker Specialists Team Up, Run Up the Companion Diagnostics Score
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
Detecting HCP Impurities in the Bioproduction Haystack
Posters
Inertial Microfluidics Enables Highly Consistent Separation and Concentration of Leukocytes from…
Upcoming Webinars
Shake-Up Your Cell Expansion Efforts
Upcoming Webinars
Smarter Biobank Management
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Companies
Merck & Co
Merck & Co
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merck & Co
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
Merck & Co
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Merck & Co
Merck & Co. Partners with Themis on Measles Virus Vector-Based Vaccines
Merck & Co
Merck & Co., Skyhawk Collaborate on RNA-Binding Small Molecule Therapies
Merck & Co
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by Acquiring Tilos for Up to $773M
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding...
Merck & Co
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
Merck & Co
Merck & Co. Plans Jobs Cuts, Shutdowns in Up-to-$1.2B Manufacturing Restructuring
Merck & Co
Merck, King’s Launch $344M+ Chronic Pain Drug Collaboration
Merck & Co
Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline
Merck & Co
Merck & Co. Partners with Sutro on Cytokine Derivatives for Cancer,...
Merck & Co
Merck Invests $125M in Moderna in Expanded mRNA Cancer Vaccine Partnership
Merck & Co
Incyte, Merck & Co. Halt Phase III Trial After Epacadostat/Keytruda Combination...
Merck & Co
Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership
Merck & Co
Merck to Acquire Oncolytic Immunotherapy Developer Viralytics for $394M
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
